^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BI-1808

    i
    Other names: BI-1808
    Associations
    News
    Trials
    Company:
    BioInvent
    Drug class:
    TNFRSF1B ligand blocker
    Associations
    News
    Trials